TitleAccelerate the route to patient benefit of new interventions to preserve beta cell function in T1D - Study Plus

Funder
Novartis Pharmaceuticals UK Ltd

Principal Investigator

Dayan,  Colin


Project Details

Net value award figure for Cardiff University£10,216.00

Start date01/01/2023

End date28/02/2025


Last updated on 2025-27-04 at 03:57